1. Home
  2. NATR vs ADCT Comparison

NATR vs ADCT Comparison

Compare NATR & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nature's Sunshine Products Inc.

NATR

Nature's Sunshine Products Inc.

HOLD

Current Price

$26.40

Market Cap

424.6M

Sector

Health Care

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.37

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATR
ADCT
Founded
1972
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.6M
484.4M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NATR
ADCT
Price
$26.40
$4.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$28.33
$7.75
AVG Volume (30 Days)
98.0K
630.5K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
165.00
30.86
EPS
1.06
N/A
Revenue
$480,144,000.00
$81,357,000.00
Revenue This Year
$7.76
N/A
Revenue Next Year
$3.82
$66.49
P/E Ratio
$25.29
N/A
Revenue Growth
5.67
14.85
52 Week Low
$11.27
$1.14
52 Week High
$28.14
$4.98

Technical Indicators

Market Signals
Indicator
NATR
ADCT
Relative Strength Index (RSI) 59.36 61.38
Support Level $23.57 $3.28
Resistance Level $26.96 $4.32
Average True Range (ATR) 0.75 0.23
MACD 0.32 0.04
Stochastic Oscillator 77.89 100.00

Price Performance

Historical Comparison
NATR
ADCT

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: